Dr. Hanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hoag Dr
Newport Beach, CA 92663Phone+1 949-764-6130Fax+1 949-764-4267
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2013 - 2014- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2012 - 2013
University of California Davis HealthResidency, Internal Medicine, 2009 - 2012
University of California, Davis, School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer Start of enrollment: 2019 May 10
- CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma Start of enrollment: 2021 Apr 29
Roles: Contact, Principal Investigator
- Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients Start of enrollment: 2018 Sep 05
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 55 citationsThe Importance of Understanding the Stages of COVID-19 in Treatment and Trials.Daniel O. Griffin, Denise Brennan-Rieder, Binh Ngo, Pierre Kory, Marco Confalonieri
AIDS Reviews. 2021-02-08 - 19 citationsThe time to offer treatments for COVID-19.Binh Ngo, Paul E. Marik, Pierre Kory, Leland Shapiro, Raphael Thomadsen
Expert Opinion on Investigational Drugs. 2021-01-01 - 33 citationsPlastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, A. Gerger, Wu Zhang, Diana L. Hanna, Dongyun Yang
Molecular Cancer Therapeutics. 2014-02-01
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
